In the very near future, possibly just days away, the FDA is anticipated to approve at least 1 new COVID-19 vaccine. Were pregnant and/or lactating women included in the phase III vaccine clinical trials? What is the safety data for the vaccine in pregnancy? Are pregnant and/or lactating women part of the vaccine distribution framework? These are tough, and even controversial, aspects that must be considered. In this session, we will review the current state of the vaccine and how it applies to pregnant/lactating women.
Activity